Log in

NASDAQ:PRAHPRA Health Sciences Stock Price, Forecast & News

$95.05
+0.13 (+0.14 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$94.58
Now: $95.05
$96.52
50-Day Range
$89.94
MA: $98.51
$109.66
52-Week Range
$58.67
Now: $95.05
$113.32
Volume313,547 shs
Average Volume420,888 shs
Market Capitalization$6.06 billion
P/E Ratio25.97
Dividend YieldN/A
Beta1.1
PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, and bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardio metabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.
Read More
PRA Health Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.54 out of 5 stars


Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRAH
CUSIPN/A
Phone919-786-8200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.07 billion
Cash Flow$6.95 per share
Book Value$17.23 per share

Profitability

Net Income$243.02 million

Miscellaneous

Employees17,500
Market Cap$6.06 billion
Next Earnings Date8/6/2020 (Confirmed)
OptionableOptionable

Receive PRAH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRAH and its competitors with MarketBeat's FREE daily newsletter.

PRA Health Sciences (NASDAQ:PRAH) Frequently Asked Questions

How has PRA Health Sciences' stock been impacted by COVID-19 (Coronavirus)?

PRA Health Sciences' stock was trading at $88.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PRAH stock has increased by 7.2% and is now trading at $95.05. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of PRA Health Sciences?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PRA Health Sciences in the last year. There are currently 6 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for PRA Health Sciences.

When is PRA Health Sciences' next earnings date?

PRA Health Sciences is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for PRA Health Sciences.

How can I listen to PRA Health Sciences' earnings call?

PRA Health Sciences will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were PRA Health Sciences' earnings last quarter?

PRA Health Sciences Inc (NASDAQ:PRAH) issued its quarterly earnings results on Thursday, April, 30th. The medical research company reported $1.05 earnings per share for the quarter, beating analysts' consensus estimates of $1.01 by $0.04. The medical research company earned $783.71 million during the quarter, compared to the consensus estimate of $749.61 million. PRA Health Sciences had a return on equity of 27.59% and a net margin of 7.66%. PRA Health Sciences's revenue for the quarter was up 8.5% on a year-over-year basis. During the same period last year, the business earned $1.10 earnings per share. View PRA Health Sciences' earnings history.

What guidance has PRA Health Sciences issued on next quarter's earnings?

PRA Health Sciences issued an update on its second quarter earnings guidance on Thursday, April, 30th. The company provided EPS guidance of $0.75-0.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.91. The company issued revenue guidance of $705-740 million, compared to the consensus revenue estimate of $666.91 million.

What price target have analysts set for PRAH?

11 equities research analysts have issued 1 year price targets for PRA Health Sciences' stock. Their forecasts range from $82.00 to $120.00. On average, they anticipate PRA Health Sciences' stock price to reach $101.00 in the next twelve months. This suggests a possible upside of 6.3% from the stock's current price. View analysts' price targets for PRA Health Sciences.

Has PRA Health Sciences been receiving favorable news coverage?

News stories about PRAH stock have trended negative this week, InfoTrie reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. PRA Health Sciences earned a news sentiment score of -2.4 on InfoTrie's scale. They also gave headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about PRA Health Sciences.

Are investors shorting PRA Health Sciences?

PRA Health Sciences saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,770,000 shares, an increase of 35.1% from the May 31st total of 1,310,000 shares. Based on an average daily volume of 504,600 shares, the short-interest ratio is presently 3.5 days. Currently, 2.8% of the shares of the company are sold short. View PRA Health Sciences' Current Options Chain.

Who are some of PRA Health Sciences' key competitors?

What other stocks do shareholders of PRA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PRA Health Sciences investors own include Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Applied Materials (AMAT), Veeva Systems (VEEV), Walt Disney (DIS), Paypal (PYPL), Home Depot (HD), Lam Research (LRCX) and UnitedHealth Group (UNH).

Who are PRA Health Sciences' key executives?

PRA Health Sciences' management team includes the following people:
  • Mr. Colin Shannon, Chairman, CEO & Pres (Age 60)
  • Mr. Michael J. Bonello, Exec. VP, CFO & Corp. Sec. (Age 49)
  • Mr. Kent Thoelke, Exec. VP & Chief Scientific Officer
  • Mr. Thomas Byrne, VP of Legal Affairs
  • Christine Rogers, Director of PR & Corp. Communications

When did PRA Health Sciences IPO?

(PRAH) raised $306 million in an initial public offering on Thursday, November 13th 2014. The company issued 17,000,000 shares at $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers.

What is PRA Health Sciences' stock symbol?

PRA Health Sciences trades on the NASDAQ under the ticker symbol "PRAH."

How do I buy shares of PRA Health Sciences?

Shares of PRAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PRA Health Sciences' stock price today?

One share of PRAH stock can currently be purchased for approximately $95.05.

How big of a company is PRA Health Sciences?

PRA Health Sciences has a market capitalization of $6.06 billion and generates $3.07 billion in revenue each year. The medical research company earns $243.02 million in net income (profit) each year or $4.80 on an earnings per share basis. PRA Health Sciences employs 17,500 workers across the globe.

What is PRA Health Sciences' official website?

The official website for PRA Health Sciences is www.prahs.com.

How can I contact PRA Health Sciences?

PRA Health Sciences' mailing address is 4130 PARKLAKE AVENUE SUITE 400, RALEIGH NC, 27612. The medical research company can be reached via phone at 919-786-8200 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.